BIOMEDICAL RESEARCH
With $52 million in federal funding, researchers at Emory University and Georgia State University will establish a groundbreaking new drug development center aimed at preventing the next pandemic.
Areas of Research
- Immunology (molecular and cellular immunology, inflammation, immunity, chemical immunology, tumor immunology, systems and computational immunology)
- Translational immunology
- Microbiology (molecular and cellular microbiology, host-pathogen interactions, microbiota, translational microbiology, systems and computational microbiology)
- Microbial pathogenesis
- Infectious diseases (COVID-19, Ebola, influenza, respiratory syncytial virus, measles, sexually transmitted infections, HIV, streptococcus pneumoniae)
- Inflammatory diseases (inflammatory bowel disease, chronic obstructive pulmonary disease, otitis media, autoimmune diseases)
- Cardiovascular diseases, diabetes and metabolic disorders
- Molecular and cellular medicine
- Translational cancer biology
- Translational medicine
- Translational systems biology and bioinformatics
- Vaccinology (flu, RSV, HIV, gonorrhea)
- Diagnostics and biomarkers
- Therapeutics and nanomedicine
Working Together to Improve Human Health
Our researchers are developing new vaccines, diagnostics and therapeutics to tackle some of the world’s biggest health issues. To bring these biomedical inventions to the market, they’d like to work with pharmaceutical and biotech companies, foundations, industry sponsors and donors who want to improve the health of people worldwide. Learn more about our patents and inventions.
Research Collaboration
A productive and well-established formal relationship among individuals or institutions is important for initiating successful research collaboration. The Institute for Biomedical Sciences has relationships with organizations around the world. Using well-defined, agreed upon division of responsibilities among the participants, the institute executes collaborative projects that increase the chances of success.
- Centers for Disease Control and Prevention
- Cornell University
- Emory University
- Georgia Institute of Technology
- Harvard University
- Mercer University
- Icahn School of Medicine at Mount Sinai
- University of Alabama at Birmingham
- University of Chicago
- University of Colorado
- University of Iowa
- University of Massachusetts
- University of Maryland
- University of Michigan
- Washington University in St Louis
- Yale University
- Animal and Plant Quarantine Agency, South Korea
- Chinese University of Hong Kong, Hong Kong, China
- DanKook University, South Korea
- Fudan University, China
- Karolinska Institutet, Stockholm, Sweden
- KonKuk University, South Korea
- Kumamoto University, Japan
- La Sapienza, Rome, Italy
- Medical Research Council, United Kingdom
- Nanjing University, China
- National Institute of Infectious Diseases, Japan
- Örebro University Hospital, Örebro, Sweden
- Paul-Ehrlich Institut, Germany
- Faculte des Sciences et Techniques, Marseille, France
- University of Bern, Switzerland
- Université de Nantes, Faculte de Medecine de Nantes, France
- Université Paul Cézanne, Equipe Biochimie Alimentaire
- Amgen, United States
- Beams Biotech, South Korea
- Korea Ginseng Corp., South Korea
- Polygene AG, Rumlang, Switzerland
- TOBICO Co. Ltd., South Korea
Featured Publications
Research Events
University Tech Transfer and Commercialization
Industry Partnerships
Industry Collaboration
Available Technologies
Additional Resources
Funding Opportunities
Internal Grant Resources
Proposal Writing Resources
Research Tech Support
Tech Commercialization
Administrative Team
We’re ready to partner with you. Please contact us to collaborate on research projects, fund preliminary pilot studies designed to advance human health or discuss commercialization opportunities.
Contact for General Questions
LaTina Emerson
Director of Communications
Institute for Biomedical Sciences
Our Address
Parker H. Petit Science Center
100 Piedmont Ave
Atlanta, GA 30303